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Abstract
Background: The aim of this study was to test seven previously published image-input methods in state-of-the-art high
resolution PET brain images. Images were obtained with a High Resolution Research Tomograph plus a resolution-recovery
reconstruction algorithm using two different radioligands with different radiometabolite fractions. Three of the methods
required arterial blood samples to scale the image-input, and four were blood-free methods.
Methods: All seven methods were tested on twelve scans with [
11C](R)-rolipram, which has a low radiometabolite fraction,
and on nineteen scans with [
11C]PBR28 (high radiometabolite fraction). Logan VT values for both blood and image inputs
were calculated using the metabolite-corrected input functions. The agreement of image-derived Logan VT values with the
reference blood-derived Logan VT values was quantified using a scoring system. Using the image input methods that gave
the most accurate results with Logan analysis, we also performed kinetic modelling with a two-tissue compartment model.
Results: For both radioligands the highest scores were obtained with two blood-based methods, while the blood-free
methods generally performed poorly. All methods gave higher scores with [
11C](R)-rolipram, which has a lower metabolite
fraction. Compartment modeling gave less reliable results, especially for the estimation of individual rate constants.
Conclusion: Our study shows that: 1) Image input methods that are validated for a specific tracer and a specific machine
may not perform equally well in a different setting; 2) despite the use of high resolution PET images, blood samples are still
necessary to obtain a reliable image input function; 3) the accuracy of image input may also vary between radioligands
depending on the magnitude of the radiometabolite fraction: the higher the metabolite fraction of a given tracer (e.g.,
[
11C]PBR28), the more difficult it is to obtain a reliable image-derived input function; and 4) in association with image inputs,
graphical analyses should be preferred over compartmental modelling.
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Introduction
Using radioligands that bind to specific receptors and enzymes,
positron emission tomography (PET) can quantify the in vivo
density of such targets in brain. This quantification, however, often
requires the concurrent measurement of the concentrations of
unchanged radioligand in arterial plasma, which is the input
function to the brain. Although insertion of an arterial catheter
rarely results in clinically relevant adverse events [1], it is laborious
and often discourages subjects from volunteering for PET studies.
As an alternative to arterial sampling, many methods have been
proposed to calculate the input function from serial images of the
internal carotid artery – i.e., an image-derived input function
[2,3,4,5,6,7,8]. Such methods have been validated for PET cameras
with a standard resolution (typically.6 mm). Some of these
methods require at least one blood sample in order to scale the
image-input, while others are completely blood-free, and therefore
more attractive. Unfortunately, blood-free methods seem to be less
accurate than blood-based methods when using a PET camera with
standard resolution [9,10], where partial volume effects are more
challenging to correct. The accuracy of blood-free methods has yet
to be verified using modern high resolution images. High resolution
images can be obtained using a tomograph with a higher intrinsic
resolution, like the HRRT (High Resolution Research Tomograph;
resolution=2.5 mm), or using reconstruction-based resolution
recovery algorithms, which are now implemented on many
standard resolution PET machines. These algorithms yield image
resolutions comparable to those offered by the HRRT scanner [11].
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17056Furthermore, most of the brain image-derived input methods
published in the literature have been validated for [
18F]FDG.
However, neuroreceptor radioligands may differ in some impor-
tant ways, including their brain distribution, vascular wash-out,
and the presence of radiometabolites in blood. As a consequence,
the accuracy of a given method may depend on the biokinetics of
the radioligand.
The aims of this study were 1) to test seven previously published
image-derived input methods (three blood-based [2,4,12] and four
blood-free methods [5,6,8,13]) from carotid arteries using high
resolution PET images, which were obtained using a HRRT and a
reconstruction-based resolution recovery algorithm, and 2) to
determine whether the percentage of radiometabolites in blood
affects quantitation with image input. Thus, we selected two
radioligands—[
11C](R)-rolipram and [
11C]PBR28—with very
different percentages of radiometabolites in blood at late scan
times. [
11C](R)-rolipram is a probe for the enzyme phosphodies-
terase 4 and has a low radiometabolite fraction - i.e. the
unchanged parent is the predominant portion of blood radioac-
tivity throughout the scan (about 80% at 90 minutes). [
11C]PBR28
binds to the translocator protein (18 kDa) and has a high
radiometabolite fraction, i.e. the parent radioligand represents
about 7% of total blood radioactivity at 90 minutes.
Materials and Methods
Subjects
Data from twelve [
11C](R)-rolipram (mean injected activity:
4106119 MBq) and nineteen [
11C]PBR28 (503641 MBq) studies
were used. Radioligands were injected in bolus over one minute.
The [
11C](R)-rolipram subjects were all healthy volunteers, while
the [
11C]PBR28 group comprised seven healthy volunteers and
twelve multiple sclerosis patients. [
11C](R)-rolipram is a tracer for
phosphodiesterase 4, a selective inhibitor of the cyclic adenosine
monophosphate (cAMP) cascade [14]. The cAMP cascade is
thought to play important roles in several psychiatric illnesses,
including depression [15] and drug addiction [16]. [
11C]PBR28 is
a marker for inflammation. It binds selectively to the translocator
protein, a mitochondrial transmembrane protein expressed in
activated macrophages and in glial cells [17]. [
11C](R)-rolipram
and [
11C]PBR28 were prepared in greater than 99% radiochem-
ical purity and high specific radioactivity. All scans were acquired
in ongoing clinical research studies that had been approved by the
Ethics Committee of the NIH. Written informed consent was
obtained from each subject.
PET scans
All scans were acquired using the HRRT (Siemens/CPS,
Knoxville, TN, USA) for 120 minutes in 33 frames except one
[
11C](R)-rolipram subject who had a 90-minute scan. Because
previous studies had shown that distribution volume values are
stably estimated within about 90 minutes of image acquisition for
both tracers [14,18], the present study only analyzed the first
90 minutes of the scans for each subject. The dynamic scan
consisted of 6 frames of 30 seconds each, then 3660 s, 26120 s
and 176300 s. All PET images were corrected for attenuation and
scatter [19]. Head motion during each scanning session was
corrected by monitoring the position of the head during the scan
with the Polaris Vicra Optical Tracking System (NDI, Waterloo,
ON, Canada) [20]. During the acquisition, blood samples (1 mL
each) were drawn from the radial artery at 15-second intervals
until 150 seconds, followed by 3 mL samples at 3, 4, 6, 8, 10, 15,
20, 30, 40, and 50 minutes, and 4.5 mL at 60, 75, 90, and
120 minutes. Whole-blood activity, the fraction of unchanged
radioligand in plasma, and the plasma/whole blood ratio were
calculated [21,22].
Magnetic resonance imaging (MRI)
To identify brain regions, MRIs were obtained for all subjects
using a 1.5-T GE Signa scanner (GE Healthcare, Piscataway, NJ,
USA). Three sets of axial images were acquired parallel to the
anterior-commissure-posterior commissure line with Spoiled
Gradient Recalled sequence of TR/TE/flip angle=12.4 ms/
5.3 ms/20u, voxel size=0.9460.9461.2 mm, and matrix=2566
256. These three MRI sets were realigned and averaged, and then
coregistered to the PET images (see below).
Image analysis
PET data were reconstructed on a 2566256 matrix with a pixel
size of 1.2261.2261.23 mm
3 using the Motion-compensation
OSEM List-mode Algorithm (MOLAR) for Resolution-recovery
[19]. Preset volumes of interest drawn in a standard space were
applied to each subject’s PET images as follows. The average MR
image from three acquisitions for each subject (see above) was
coregistered using SPM5 to the average PET image created from
all frames. Both MR and all PET images were spatially normalized
to a standard anatomic orientation (Montreal Neurological
Institute space) based on transformation parameters from the
MR images. Preset volumes of interest were positioned on the
spatially normalized MR images to overlie thalamus (12.6 cm
3),
caudate (5.6 cm
3), putamen (6.5 cm
3), cerebellum (51.2 cm
3),
frontal (27.2 cm
3), parietal (26.6 cm
3), lateral temporal (25.0 cm
3),
occipital (31.2 cm
3), anterior cingulate (7.5 cm
3), and medial
temporal (14.3 cm
3) cortices. Image analysis was performed using
PMOD 3.0 (pixel-wise modeling software; PMOD Technologies
Ltd., Zurich, Switzerland) and the BrainVISA/Anatomist software
(SHFJ/Neurospin, CEA, Orsay, France).
Input Function Extraction Methods
The seven methods compared in this study can be classified into
two groups: the first three are blood-based methods (those which
require some blood samples to scale the image-input) and the last
four are blood-free methods.
Chen’s method. Carotid and background regions of interest
were manually drawn directly on the summed PET frames of the
first two minutes and then copied to all the frames (the same sets of
regions of interest (ROI) were also used to calculate the image
input using the methods of Su and Parker; see below). The carotid
signal measured from the images was represented as a linear
combination of the radioactivity from the blood and spill-in from
the surrounding tissue [2]:
Ccarotid t ðÞ ~RC|Cwb t ðÞ zSP|Csurround t ðÞ ð 1Þ
where Ccarotid is the concentration of radioactivity obtained from
the carotid region in the PET image; Cwb is the concentration of
radioactivity in whole blood sampled directly from the radial
catheter; RC is the recovery coefficient necessary to correct the
carotid PET measurement for resolution blurring effect; SP is the
percentage spill-in from surrounding tissues to the carotid region;
and Csurround is the radioactivity in the surrounding tissues
obtained from a comma-shaped ROI drawn in the proximity,
but not immediately adjacent, to the carotid region. RC and SP
were estimated with the linear least squares method by using
Ccarotid,C wb, and Csurround in equation (1) at 6, 20, 60 and
90 minutes for [
11C](R)-rolipram studies and at 4, 20, 60 and
90 minutes for [
11C]PBR28 studies.
Image Input Function in High Resolution PET Images
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reconstruction algorithm that includes modelling of the tomograph
spatial resolution [12]. During reconstruction with the Motion-
compensation OSEM List-mode Algorithm, resolution recovery is
achieved by the use of a 3D Gaussian function with full width at
half maximum (FWHM) of 2.5 mm [19]. The image-input was
obtained by averaging the cluster of the four hottest pixels per
plane within the carotids, as defined in the early summed frames.
The resulting image-input curves were first fitted with a tri-
exponential function, and then scaled using the mean of the ratio
between three arterial whole blood samples at 20, 60, and
90 minutes, and the activity of the fitted image-input at the
corresponding time points.
Naganawa’s method. The approach proposed by Naganawa
and colleagues is based on the Independent Component Analysis
(ICA) [4]. With ICA, time-activity curves are extracted without
any anatomical assumption and spill-over effects are implicitly
accounted for through the source signal mixing process. The ICA
algorithm used in the present study is EPICA (http://home.att.ne.
jp/lemon/mikan/EPICA.html). Images were first cropped in order
to eliminate most of the background activity and then smoothed
with a 6 mm FWHM Gaussian filter (smoothing was necessary in
order to better identify image-input, owing to the sensitivity of the
ICA algorithm to the noise of HRRT images). Because ICA cannot
determine the absolute amplitude of the independent components,
we scaled the final curves using Mourik’s three-blood-sample
method described above.
Su’s method. Su used Chen’s formula, but replaced the
whole-blood sample values with the local frame-wise hottest voxel
from the carotids over the first 30 minutes of the acquisition after
[
18F]FDG injection [5]. In order to assess the optimal time for our
tracers, we increasingly truncated, with 10 minute increments, the
hottest voxel time-activity curves from the initial length of
90 minutes to only the initial 10 minutes and calculated the
corresponding image input function at every step. The mean area
under the curve for each set of image inputs was compared to the
mean area under the curve of the reference arterial input. Timing
that gave the ratio closest to 1 was selected. The final VT values
were calculated from image-inputs obtained using the hottest
carotid voxel for the first 20 minutes for [
11C](R)-rolipram and the
first 40 minutes for [
11C]PBR28.
Parker’s method. This method also relies on Chen’s basic
formula. The whole-blood samples values are estimated by using
Imax, which is derived from the mean of the hottest 5% data points
in the carotids [6]. At the end of the scan, if the surrounding tissue
activity exceeds blood activity, Imax is corrected to Imax6Imean/
Tmean, where Imean and Tmean are the mean values over the carotid
and over the tissue background regions, respectively.
Backes’ method. The whole-blood concentration, Cwb(t), is
obtained from the measured concentration Ccarotid(t) by:
Cwb(t)~
1
avz(1{av):(1{e{kt)
Ccarotid(t) ð2Þ
where av takes into account the fractional volume of the vessel
within the ROI, and k is the constant for the transport from the
vessel to the surrounding tissue [13]. The factors av and k must be
empirically determined. To extract carotid time-activity curves, we
used two squared ROIs centered on each carotid over four slices.
We applied equation (2) using combinations of av values of 0.3, 0.4,
and 0.5, and k values of 5610
21,5 610
22,5 610
23, and
5610
24 min
21 to calculate the image input. We then compared
the mean area under the curve for each set of image inputs to the
mean area under the curve of the reference arterial input and
selected the combination of values that gave the ratio closest to 1.
The chosen values were av=0.4 and k=5 610
24 min
21 for
[
11C](R)-rolipram, and av=0.5 and k=5 610
22 min
21 for
[
11C]PBR28 studies.
Croteau’s method. The carotid diameter was measured on
the MRI scan of each subject by averaging the diameters of both
carotids over three adjacent planes below the skull. In the same
planes, carotid time-activity curves were obtained by averaging the
four hottest pixels on the PET images. The final, very noisy, time-
activity curves were first fitted with a tri-exponential function and
then corrected for partial volume effect (but not for spill-in) by
applying a recovery coefficient proportional to the carotid diameter
[8]. Recovery coefficients were obtained by averaging the four
hottest pixels of the images obtained from an analytic simulator,
using the same resolution and voxel size of the PET images.
Recovery coefficients were calculated for diameters ranging from 3
to 8 mm, with 0.1 mm steps. To test the accuracy of the simulated
coefficients, we imaged 2 syringeson the HRRT, with a diameterof
3.6 and 4.8 mm respectively, containing a concentration of
2.9 MBq/mL of
11C. The mean simulated/measured coefficient
ratio for these two diameters was 0.995. In contrast to Croteau’s
paper, we did not calculate the relationship between the FWHM of
the object measured on the PET images and the actual diameter of
the object. Instead, we directly used the carotid diameter measured
on the MRI as a more precise way to determine carotid size, and
hence the correct recovery coefficient.
Figures of merit
Visual comparison. Whole-blood image-inputs obtained
with each method were first visually compared with the reference
arterial whole-blood time-activity curves. We compared the overall
shape of the curves and in particular how well the image inputs
matched the height of the peaks and the slope of the tails of the
reference arterial curves.
Area under the curve (AUC) ratios. The mean area under
the curve (AUC) ratio between the image-derived and arterial
time-activity curves was calculated for each tracer. We compared
the image/arterial AUC ratios of both the whole-blood and the
metabolite-corrected parent time-activity curves. Metabolite
correction for the image-inputs was performed by multiplying
the image-derived whole blood curve with the parent/whole blood
ratios at each time point (interpolated to agree with the scanner
time points at the beginning of each frame).
Kinetic modelling. Both arterial and image inputs were first
corrected for metabolites, then distribution volume (VT) values
were obtained using the Logan analysis. We calculated the image/
blood mean Logan VT ratio for each subject. A scoring system was
used to compare the different methods. We gave 2 points if the
image/arterial VT ratio comprised between 65%, 1 point if
comprised between 65–10%, and 0 points if higher than 610%.
Compartment modeling was also performed using the methods
that gave the most accurate results with Logan analysis. Delay of
the input functions was corrected by fitting the input functions
with the brain time-activity curves. The blood volume was set at 0
and VT values and individual rate constants (K1,k 2,k 3 and k4)
were calculated using an unconstrained two-tissue compartment
model. We calculated the image/blood mean ratio of these
parameters for each subject. When the non-linear least square
fitting occasionally did not converge in a parameter of one region,
that region was excluded from the analysis.
Phantom simulations
We used two MRI-based numerical phantoms of the human
brain [23], into which two sets of internal carotids, with a diameter
Image Input Function in High Resolution PET Images
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of 19 anatomic labels, corresponding to the anatomical regions of
the head of the phantoms, including carotids, frontal, temporal,
parietal and occipital grey matter, white matter, basal ganglia,
bones, and soft tissues. For each label, we defined a time-activity
curve, obtained by averaging the corresponding time-activity
curves of the [
11C](R)-rolipram and [
11C]PBR28 clinical studies.
The time-activity curve defined for carotid labels was the
reference ‘‘arterial’’ whole-blood input function. The simulated
time-activity curves for each region were used as input of an
analytic fast simulator [24], recently upgraded to simulate HRRT
studies [25]. This simulator takes into account true, scattered,
and random coincidence detector efficiencies and includes a
realistic detector resolution model for the HRRT [25]. Noisy
sinograms were generated based on the same time frame used in
the clinical studies. A realistic noise level was achieved by
calibrating the true, random, and scatter events and noise-
equivalent count rates of the phantoms with those of the clinical
data. The simulated noisy sinograms were reconstructed with
the OP-OSEM algorithm, with 16 subsets and 10 iterations.
The voxel size of the reconstructed images was set to
1.2261.2261.22 mm
3. The image-based Point Spread Function
model was used during the reconstruction, in both the forward-
and back-projection, with an isotropic and stationary 3D kernel
given by:
f(x)~e
{0:5: x
s1
 2
zr:e
{0:5: x
s2
 2
ð4Þ
With s1=0.9mm, s2=2.5 mm, and r=0.07. This resolution
model was validated for the HRRT scanner by Comtat and
colleagues [26].
In total, the dynamic PET phantom was computed by linear
combination of the phantom structures, weighted by the
associated kinetics, and sampled into time frames whose number
and duration time were identical to those of the clinical studies
(see below). The dynamic phantom was forward projected and
noise was added, taking into account scattered and random
coincidences (Figure 1). Image-input was calculated for all
phantoms using the methods of Chen and Mourik. The fraction
of unchanged parent was derived by multiplying the ‘‘arterial’’
and image input of the phantoms by the average parent/whole
blood time activity curve measured in the clinical scans, after
linear interpolation of the blood data to match the PET time
schedule.
Results
Blood analyses
The shape of the whole-blood curves was very similar for
the two tracers (Figure 2AB), with a concentration peak at
,90 seconds and a rapid decline thereafter; however, the
relative concentration of parent and metabolites differed
(Figure 2C). [
11C](R)-rolipram remained the predominant
portion of blood radioactivity throughout the scan. The mean
parent/whole blood ratio was of about 1 (0.9960.24) at
60 minutes after injection, and 0.8060.30 at 90 minutes. In
contrast, for [
11C]PBR28, radiometabolites became the predom-
inant component of blood radioactivity for most of the scan. The
mean parent/whole blood ratio was of about 1 (0.9660.13) at
4 minutes after injection, and 0.0760.02 at 90 minutes. The
mean/whole blood ratios are calculated from all the subjects
used in this study (n=12 for [
11C](R)-rolipram and n=19 for
[
11C]PBR28).
Accuracy of the image-derived input function
Visual analysis. For both tracers, none of the methods could
consistently reproduce the height and shape of the reference
arterial peaks. In general, however, the blood-based methods
provided a better estimate of the late part (i.e. the tails) of the
curves than the blood-free methods (Figure 3).
Using Chen’s methods, the tails, but not the peaks, of image-
inputs matched closely the arterial inputs for both tracers. The
peaks were generally slightly underestimated, although an
overestimation was observed for several patients. Mourik’s method
gave similar results: a closely matching tail and a less accurate
peak, although with this method an overestimation of the peak was
more common. With Naganawa’s method the late part of the tail
of the image-inputs, in general, successfully followed the reference
arterial input. However, there were often considerable errors in
the estimation of the peaks (and often in the early part of the tails),
both in the height (significant under- and over-estimations) and in
the shape (sometimes a bicuspid peak was observed). Using the
methods of Su and Parker, overestimations of both the peak and
the tail of the curves, to a variable degree, were observed for most
subjects and for both tracers. With the method of Backes, the
peaks were consistently underestimated for all subjects and for
both tracers, while the tails sometimes showed an under- or over-
estimation, but usually of modest entity. Finally, Croteau’s method
underestimated the curves to a variable degree with both tracers.
Area under the curve ratios. In addition to the visual
analysis, we performed a quantitative analysis by calculating the
mean ratio of the AUCs for both the whole-blood and parent
curves. In general, the difference of the mean AUC ratio was
smaller for the blood-based methods than for the blood-free
methods. Interestingly, while no significant difference was noted
between the whole-blood and parent AUC ratios for [
11C](R)-
rolipram, the whole-blood AUC ratios for [
11C]PBR28 were on
average better than the parent ratios (Table 1).
For [
11C](R)-rolipram, the difference of mean AUC ratio was
,10% for the three blood-based methods and for the method of
Backes in the whole-blood curves; these values did not significantly
change after metabolite correction. For the methods of Su and
Parker the mean ratio was much higher than 1 for both sets of
curves, while Croteau’s method yielded a ratio much lower than 1
(Table 1).
For [
11C]PBR28, the difference of the mean AUC ratio for the
whole blood curve was ,10% for the three blood-based methods
and for the method of Backes. After metabolite correction, the
AUC ratio for the parent time-activity curves showed a greater
error for all these four methods. Much less accurate results were
obtained for both sets of curves with the three remaining blood-
free methods (Table 1).
Kinetic modelling. As expected from the results of the AUC
ratios, the best results were obtained for both tracers with two of
the blood-based methods—those of Chen (22/24 for [
11C](R)-
rolipram) and Mourik (18/38 for [
11C]PBR28). The best results
using a blood-free method were obtained using the method of
Backes (13/24 for [
11C](R)-rolipram and 9/38 for [
11C]PBR28).
Notably, the scores for each method were consistently higher for
[
11C](R)-rolipram than for [
11C]PBR28 (Table 2). When the
image input gave an inaccurate estimation of the reference input
function, the error in VT estimation was of the same magnitude in
all the brain regions, regardless of the respective binding levels.
Compartment modeling was performed for both tracers using
the image inputs obtained with the methods of Chen and Mourik
and an unconstrained two-tissue compartment model. The
resulting individual rate constants showed important and unpre-
dictable errors in both tracers and with both methods (Table 3).
Image Input Function in High Resolution PET Images
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11C](R)-rolipram brain scan of a healthy volunteer and from a simulated study using a digital
phantom. Upper row: [
11C](R)-rolipram images across the thalamus summed over the whole duration of the scan from a phantom (A) and a healthy
volunteer (B). The phantom images are realistic and quite similar to those from the real subjects. The external rim of activity surrounding the brain, in
both the subject and the phantom, is scalp activity. Middle row: images summed over the first two minutes at the carotid level. The carotids are well
visible near the temporal lobes for both the phantom (C) and the healthy volunteer (D). The regions of high activity visible in the lower part of the
cerebellum of the subject (D) are the cerebellar venous sinuses (not simulated in the phantom studies). Bottom row: late images (three summed
frames taken at about 1 hour after injection) from a phantom (E) and a subject (F). At late times the carotids are not well visible anymore and the
spill-over effect from surrounding tissues becomes more important.
doi:10.1371/journal.pone.0017056.g001
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modeling, which are derived from the individual rate constants,
were much less accurate than those obtained with the Logan plots.
For example, the score for [
11C](R)-rolipram changed from 22/24
to 19/24 using the method of Chen and from 16/24 to 7/24 using
the method of Mourik (Table 2).
Phantom simulations
We suspected that an imperfect estimation of the peak, due to a
coarse temporal framing, was responsible for the more accurate
Logan VT estimations with [
11C](R)-rolipram than with
[
11C]PBR28. To verify this hypothesis, we performed digital
phantom simulations. In these phantoms, the carotid signal is not
averaged over the duration of the frames, because each frame
corresponds to a punctual detection at a given time. All the other
possible sources of error in the estimation of the peaks (i.e. noise,
random counts, partial volume effect, spill-over) are faithfully
simulated. Our results show that, when the peak signal is not
averaged over the duration of the frames, image-input methods
may accurately estimate Logan VT values even for tracers with a
high metabolite fraction (like [
11C]PBR28). Indeed, a correct
estimation of the peak is more important for [
11C]PBR28 than for
[
11C](R)-rolipram (see Discussion).
The image-inputs estimated with the methods of Chen and
Mourik were very similar to the reference input functions for the
four phantom simulations. The tails of the curves matched closely,
and only minor differences in height were observed for the peaks.
For both tracers, the mean AUC ratio was close to 1, both before
and after metabolite correction. No significant differences were
noted between the curves calculated from carotids of different size.
The Logan VT estimations were very accurate for both [
11C](R)-
rolipram and [
11C]PBR28 phantoms (Table 4). For [
11C](R)-
rolipram, the resulting Logan VT values were similar to those
found in the clinical scans, while for [
11C]PBR28 the phantom
Logan VT values were more accurate than the average values
obtained from the clinical data.
Discussion
This study tested seven different image-derived input function
methods on dynamic high resolution brain PET scans. Three of
these methods require blood samples to scale the image input and
four are blood-free. Corroborating a previous study done on
standard resolution PET images [9], we found that the most
accurate image input estimations were obtained using two blood-
based image input methods (Chen and Mourik), while blood-free
methods were generally less reliable. Chen’s method uses some
blood samples to estimate the partial volume and spill-over
correction coefficient, which results in good estimates of the tail of
the input function [2]. Mourik’s method relies on defining small
ROIs within the carotids to avoid contamination by the
background activity. This method allows the estimation of a
completely blood-free image input with some tracers on PET
machines with a standard resolution [3,27]. However, blood
samples are necessary when using this method on HRRT,
probably because of a higher scatter contribution [12]. Mourik’s
method also provides a better estimate of the peak than the other
methods assessed here, which is particularly important for tracers
with a high metabolite fraction (see below). Naganawa’s method
takes advantage of ICA to extract the image-input without any
anatomical prior. This clever method has been shown to yield
good results with clinical PET scanners for [
18F]FDG [4] and
[
11C]MPDX, a tracer for adenosine receptors [28]. However, in
the present study, results with this method were less accurate, likely
Figure 2. The average concentrations of radioactivity in whole
blood (solid line) and parent radioligand in plasma (dashed
line) over time for [
11C](R)-rolipram (n=12) (A) and [
11C]PBR28
(n=19) (B). The main figures show the first 20 minutes of the curves
and the inserts the remaining part. Although the shape of the whole
blood curves was similar for the two tracers, the relative concentration
of parent and metabolites differed. The mean ratio of concentration of
parent radioligand in plasma to total radioactivity in whole blood (C)
showed that [
11C](R)-rolipram remained the predominant component of
whole blood radioactivity throughout the scan. In contrast, radio-
metabolites of [
11C]PBR28 became the predominant component of
whole blood radioactivity after the first few minutes.
doi:10.1371/journal.pone.0017056.g002
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resolution images.
Performance of the four blood-free methods was generally poor.
The methods of Su and Parker yielded an inaccurate estimate of
VT values with both tracers, mainly because these two methods
gave a poor estimation not only of the peaks, but also of the tails of
the input functions. In general, blood-free methods that rely on a
limited number of voxels to estimate blood activity are
theoretically attractive. However, their accuracy may be heavily
and unpredictably influenced by a number of parameters such as
noise levels, scatter correction methods, reconstruction algorithms,
filtering parameters, and tracer biodistribution. Among the blood-
free methods assessed here, the best results were obtained with the
method of Backes. This method is less sensitive to noise, and the
parameters av and k are independent of scanner type [13]. Because
this method was originally validated on a standard resolution PET
Figure 3. The concentrations over time of [
11C](R)-rolipram (A and B) and [
11C]PBR28 (C and D) in plasma from the arterial input
function (solid line) and from the image input function (dashed line) of a representative healthy subject. The curves are representative
of those from a blood-based (Chen; A and C) and a blood-free (Su; B and D). None of the methods precisely estimated the peak in all the subjects
but, in general, blood-based methods yielded a better estimate of the tails of the curves.
doi:10.1371/journal.pone.0017056.g003
Table 1. AUC ratio (mean 6 SD) calculated for each method and for both whole-blood and plasma curves for each tracer.
Blood-based methods Blood-free methods
Chen Mourik Naganawa Su Parker Backes Croteau
[
11C](R)-rolipram Whole-blood 1.0360.04 1.0760.10 0.9660.21 1.4960.28 1.2860.21 1.0360.10 0.3660.12
Plasma 1.0060.04 1.0660.13 0.9860.38 1.4760.26 1.2460.20 0.9860.09 0.3560.14
[
11C]PBR28 Whole-blood 1.0360.12 0.9660.04 0.9660.08 3.6961.57 2.6560.76 1.0060.24 0.5560.11
Plasma 0.9360.15 0.9260.09 0.9160.19 3.0761.24 2.1860.60 0.8560.21 0.5260.10
The AUC ratio is on average more accurate for blood-based methods than for blood-free methods. For [
11C]PBR28, but not for [
11C](R)-rolipram, the parent AUC ratios of
the blood-based methods are less accurate than the whole-blood AUC ratios.
doi:10.1371/journal.pone.0017056.t001
Image Input Function in High Resolution PET Images
PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e17056machine using venous sinuses as a source of image-derived input,
the carotid blood pool should theoretically provide a more
accurate estimate of the input function. However, Backes showed
that because of the small size and sensitivity to motion, the carotid
time-activity curves were too noisy to be used for kinetic modeling
[13]. In the present study, images had a higher spatial resolution
and movements were corrected by an on-line motion correction
system. Therefore, the inaccurate results sometimes found with
this method are probably due to inter-subject variability in carotid
size and in the tracer diffusion to the extravascular compartment,
i.e. the av and k factors of the formula (2). Such inter-subject
variability is not taken into account in (2).
Croteau’s method yielded poor results with both tracers. This
method seems to be very sensitive to errors. Croteau showed that
an underestimation of the diameter of the carotid artery by just
1 mm would induce an error in the cerebral metabolic rate of
glucose of about 17% [8]. Even larger errors were found when this
method was applied to femoral arteries: an under/overestimation
of the artery size of 1 mm entailed an under/overestimation of
,66% in the perfusion index measured with [
11C]acetate [8].
Clearly, the scaling of the image input through recovery
coefficients can be very sensitive to errors, and scaling with blood
samples should be preferred.
In summary, most of the image input methods tested in the
present study on [
11C](R)-rolipram and [
11C]PBR28 gave poor
results. This suggests that image input methods that are validated
and work well on a given tracer do not necessarily perform equally
well when applied to other tracers (despite the use of high
resolution images). For instance, using the image input method we
previously validated for [
11C](R)-rolipram [14], we were unable to
obtain equally reliable results for any other tracer of our database.
That is because different tracers may show different biodistribu-
tion characteristics, such as a more or less strong carotid signal or
different levels of background (i.e. cortical and soft tissue) uptake.
As a consequence, a different biodistribution may entail spill-over
effects of different magnitude. In our (unpublished) experience,
among the factors that make image input methods fail there are a
low carotid signal and an excessively high early spill-over from
surrounding tissues. Examples of such tracers are [
18F]-FMPEP-d2
[29], [
11C]-MePPEP [30], [
11C]-DASB [31] and [
18F]-SP203
[32].
Three of the methods we evaluated in our previous comparison
[9] have not been reassessed in the present work. The method of
Litton [33] uses recovery coefficients empirically determined to
correct for partial volume effect and therefore is similar to the
more recent and better validated method of Croteau [8]. The
method of Bodvarsson uses a Nonnegative Matrix Factorization
approach to extract the input function [34]. However, the
factorization algorithm used [35] suffers from the existence of
local minima. The use of random matrix to initialize the algorithm
can make the algorithm converge to these minima, in particular in
noisy high-resolution HRRT images. The third one is a method
we previously proposed in abstract form [36], in which partial
volume effect is corrected using the Geometric Transfer Matrix
approach [37]. However, our method performed poorly when we
compared it to other published methods [9]. Subsequent
(unpublished) phantom simulations showed that our method does
not allow a full recovery of partial volume effect and moreover is
very sensitive to minor errors in carotid segmentation. Therefore it
is too unreliable to be used in clinical practice.
When a Logan plot is used to obtain VT, the relationship
between the plasma AUC and VT values is quite straightforward,
as the Logan plot mainly relies on the integral of the AUC.
Therefore, an overestimation of about 20% of the plasma AUC
would lead to an underestimation of Logan-VT of the same order
of magnitude. This can be easily seen by comparing the results
reported in the plasma AUC (Table 1) to those reported in the VT
(Table 2). Although the graphical methods may carry forward any
Table 2. Image/blood VT ratios (mean 6 SD) and scores calculated for each method.
Blood-based methods Blood-free methods
Chen
(Logan)
Chen
(2TCM)
Mourik
(Logan)
Mourik
(2TCM)
Naganawa
(Logan)
Su
(Logan)
Parker
(Logan)
Backes
(Logan)
Croteau
(Logan)
[
11C](R)-rolipram VT Ratio 0.9960.04 1.0060.05 0.9760.07 1.2260.32 1.0960.19 0.7460.19 0.8260.15 0.9760.11 3.3561.81
Score 22/24 19/24 16/24 7/24 6/24 3/24 4/24 13/24 0/24
[
11C]PBR28 VT Ratio 1.1060.17 1.1560.20 1.0860.09 1.2960.23 1.1160.14 0.3660.14 0.4660.11 1.1960.28 1.9460.43
Score 11/38 12/38 18/38 5/38 7/38 0/38 0/38 9/38 0/38
The scores are calculated by giving 2 points each time the image/arterial VT ratio comprised between 65%, 1 point if comprised between 65–10%, and 0 points if
higher than 610%. The most accurate results for both tracers were obtained using two blood-based methods (Chen and Mourik) and the Logan plot. When VT ratios
were calculated using these two blood-based methods and an unconstrained two-tissue compartment model (2TCM), the overall results were less accurate. Please note
that even if the Chen-[
11C]PBR28 score is comparable between the two modeling approaches (11/38 vs. 12/38), the 2TCM yields a greater bias and a greater standard
deviation of the mean VT ratio (1.1060.17 vs. 1.1560.20).
doi:10.1371/journal.pone.0017056.t002
Table 3. Image/blood ratio of the individual rate constants obtained with an unconstrained two-tissue compartment model.
Chen Mourik
K1 k2 k3 k4 K1 k2 k3 k4
[
11C](R)-rolipram 1.7860.29 2.0762.42 1.3061.16 1.1360.50 0.8260.29 0.8160.43 1.0960.89 0.8560.58
[
11C]PBR28 1.9661.40 1.6461.27 0.8060.29 0.9160.42 1.1860.33 0.7160.30 0.4660.21 0.6860.18
doi:10.1371/journal.pone.0017056.t003
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progressive integrals of the AUC, in the case of Logan plots this
does not matter that much because this technique relies mostly on
the late parts of the curve (pseudoequilibrium). In contrast, in the
case of Patlak plots any error in the early part of the input function
may affect overall scaling and thus have a direct effect on the
slope. However, even for Patlak plots, errors in the estimation of
the peak should have only moderate consequences on the results of
kinetic modeling. Using [
18F]FDG and the Patlak plot, Chen
showed that an underestimation of about 20% of the peak would
cause less than 0.1% variation on the estimated metabolic rates of
glucose [2].
On the other hand, when using a two-tissue compartmental
model, the shape of the input function becomes a critical factor. In
fact, VT it is derived from the individual rate constants according
to the formula
K1
k2
1z
k3
k4

. Individual rate constants are very
sensitive to variations in the shape of the curve, which may not be
well-estimated using image inputs. Corroborating a previous study
with [
18F]-FDG [9], the present study shows that image input does
not reliably estimate individual rate constants. Such rate constants
will usually carry much larger random errors than compound
parameters(suchasKi,VT,andBindingPotential).Whencalculating
compound parameters from individual rate constants, some of the
random errors in the latter will cancel out, providing relative stability
to the compound parameters. However, VT calculated with a two-
tissue compartmental model was still less accurate than that obtained
with the Logan plot. Therefore, the present study and the previous
one [9] suggest that image inputs should be preferably used in
association with graphical analyses. While producing smaller
random errors, graphical methods are however potentially vulner-
able to bias and this bias is mostly linked to the accuracy of the
estimation of the later parts of the input functions. Therefore, the
most reliable results were obtained by those image-input methods
that provided a better estimation of the tail of the curves.
One important limitation of image-derived input function is that
image inputs cannot distinguish the parent compound from its
radioactive metabolites. The different image input methods for
neuroreceptor tracers described heretofore in the literature have
not addressed the problem of individual metabolite correction.
Some studies estimated only the whole-blood curve from images,
and the percentage of unchanged parent (the true input function)
was obtained at each time point by correcting the image input
using HPLC analysis from arterial blood sampling [3,27], thus
diminishing the practical utility of the proposed method. Other
studies did not perform metabolite correction [28,33]. Naganawa
and colleagues calculated [
11C]MPDX whole-blood time-activity
curve using ICA and stated that the metabolite fraction for this
tracer is negligible [28]. However, according to a previous study,
76% of administered [
11C]MPDX remains intact 60 minutes after
injection [38]. It is questionable whether an error of up to ,25%
in the estimated parent concentration can be safely overlooked.
The use of a population-based average metabolite fraction
would eliminate the need of arterial sampling to correct the whole-
blood time activity curves obtained from images. However, this
approach must be validated for each tracer. In this study, using an
average metabolite curve instead of individual metabolite
correction for the [
11C](R)-rolipram image inputs calculated with
the method of Chen would have caused an important loss of
accuracy. In fact, we recalculated the Logan VT values and the
relative scores after metabolite correction using an average
population-based metabolite curve. As compared to individual
metabolite correction, the mean Logan VT ratio changed from
0.9960.04 to 0.9860.20 and the score changed from 22/24 to
only 5/24. A previous study from our laboratory demonstrated
that individual metabolite correction can be successfully integrated
in the image input calculation algorithm without increasing the
invasiveness of the procedure [14]. However, investigating possible
approaches of metabolite correction is outside the scope of the
present comparative study. Therefore, we performed metabolite
correction using the reference method, i.e. calculating the
unchanged parent at each time point using HPLC analysis. In
this way, we also avoided the additional source of uncertainty
associated with estimating the metabolite fraction.
In the present study, we also showed that the magnitude of the
metabolite fraction may significantly impact the accuracy of the
image-input, as the scores for each method were consistently
higher for [
11C](R)-rolipram—which has a lower metabolite
fraction in plasma—than for [
11C]PBR28 scans. The shape of
the early part of an input function is characterized by rapid
changes in radioactivity concentration over time, and is therefore
always difficult to estimate accurately from PET images. The
Logan plot uses the AUC of the input function and therefore is not
very sensitive to the accuracy of peak estimation. In fact, when we
used Chen’s method in the present study, we found that the
[
11C](R)-rolipram mean image/blood AUC ratio for whole-blood
curves was close to 1, and that this figure did not change
significantly after metabolite correction (Table 1). Therefore,
correctly estimating the peak does not appear to be critical for
Logan VT calculation in ligands with a low metabolite fraction.
The situation is different in ligands with a high metabolite
fraction. For [
11C]PBR28, after whole-blood curves were corrected
for metabolites, the total area under the tail dramatically decreased
(Figure 2B), and the accuracy of Logan VT values became more
dependent on the unreliable area under the peak. While the whole-
blood AUC ratio calculated using Chen’s method is also close to 1,
the mean metabolite-corrected parent AUC ratio is less precise
(Table 1). The same pattern is found for all the other methods that
provide a good estimation of the tail (Mourik, Naganawa, Backes).
This suggests that accurately estimating the peak becomes more
critical for ligands with a high metabolite fraction, since the peak
now accounts for a larger proportion of the total parent AUC.
Theoretically, a more rapid PET framing should allow for
better definition of the peak. However, in short dynamic HRRT
frames the noise increases considerably and quantification
becomes difficult. Moreover, even using the two most reliable
methods (Chen and Mourik), the errors in the peaks estimation
were very variable for the same original time-framing. We
observed unpredictable underestimations and occasional overesti-
mations of the peaks. This is partly due to the noise in the images,
but also raises the hypothesis of possible inaccuracies in the
calculation of the reference arterial peaks, which are obtained by
discrete arterial sampling. Therefore, to eliminate these confound-
ing factors, instead of modifying the time-framing of the clinical
PET scans, we chose to perform phantom simulations, where the
height of the peaks is perfectly known.
Table 4. Results of the phantom simulation.
[
11C](R)-rolipram [
11C]-PBR28
Chen Mourik Chen Mourik
Whole-blood AUC ratio 1.059 1.007 1.019 1.025
Plasma AUC ratio 1.049 1.007 1.027 1.068
Logan VT ratio 0.948 0.994 0.986 0.949
doi:10.1371/journal.pone.0017056.t004
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estimation was the principal cause of Logan VT inaccuracy using
tracers with a high metabolite fraction. In the phantom data, the
height of the peaks was perfectly known and the carotid signal was
not averaged over the duration of the frames, as each frame
corresponded to a punctual detection at a given time; that is, the
temporal sampling was ‘‘ideal’’ or ‘‘perfectly matched’’. All other
possible sources of error in estimating the peaks (i.e. noise, random
counts, partial volume effect, spill-over) were faithfully simulated.
In other words, and contrary to clinical data, the phantom peaks
were no more difficult to estimate than the tail. The results of the
simulation confirms that a better estimation of the peak is critical
for accurately estimating Logan VT using tracers with a high
metabolite fraction like [
11C]PBR28. Indeed, a better estimation
of the peak has little influence on estimating Logan VT values for
tracers with a low metabolite fraction, like [
11C](R)-rolipram.
These findings can be extrapolated to other neuroreceptor
tracers: the higher the metabolite fraction of a given tracer, the
more difficult it will be to obtain a reliable image-derived input
function. Therefore, if a tracer is known to have a high metabolite
fraction, serial blood sampling is likely to give better results than
image input.
In conclusion, our study on image input function of [
11C](R)-
rolipram and [
11C]PBR28 in high resolution PET images has
demonstrated that image derived input with limited blood samples
works satisfactorily with [
11C](R)-rolipram but not with
[
11C]PBR28 and when a Logan analysis is used to calculate VT,
but not a two-tissue compartment model. The biokinetics of the
two tracers we used in the present study is representative of that of
many other tracers. Thus several more generalizable conclusions
can be made as follows:
1) Image input methods validated for a specific tracer and a
specific machine may not perform equally well in a different
setting. Therefore, careful evaluation and previous valida-
tion is necessary when applying a method to a particular
radioligand in clinical practice.
2) Despite the use of high resolution PET images, blood
samples are still necessary for obtaining reliable image input
function.
3) The accuracy of image input may also vary between
radioligands depending on the magnitude of the radio-
metabolite fraction: the higher the metabolite fraction of a
given tracer, the more difficult it is to obtain a reliable
image-derived input function.
4) When using an image input, the total area under the curve
of the input function is easier to estimate than its shape.
Therefore, kinetic modeling performed using graphical
analyses (such as the Logan plot), which rely on the integral
of the area under the curve, is likely to give more reliable
results than when using compartmental modeling.
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